Exact Mass: 596.3349

Exact Mass Matches: 596.3349

Found 29 metabolites which its exact mass value is equals to given mass value 596.3349, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

L 681512-2

L 681512-2

C32H52O8S (596.3383)


   

piscidinone B

piscidinone B

C35H48O8 (596.3349)


   

Phe Phe Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]hexanamido]-5-carbamimidamidopentanoic acid

C30H44N8O5 (596.3434)


   

Phe Phe Arg Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]hexanoic acid

C30H44N8O5 (596.3434)


   

Phe Lys Phe Arg

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C30H44N8O5 (596.3434)


   

Phe Lys Arg Phe

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C30H44N8O5 (596.3434)


   

Phe Arg Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]hexanoic acid

C30H44N8O5 (596.3434)


   

Phe Arg Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]hexanamido]-3-phenylpropanoic acid

C30H44N8O5 (596.3434)


   

Lys Phe Phe Arg

(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]-3-phenylpropanamido]pentanoic acid

C30H44N8O5 (596.3434)


   

Lys Phe Arg Phe

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]pentanamido]-3-phenylpropanoic acid

C30H44N8O5 (596.3434)


   

Lys Arg Phe Phe

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]-3-phenylpropanamido]-3-phenylpropanoic acid

C30H44N8O5 (596.3434)


   

Arg Phe Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-phenylpropanamido]hexanoic acid

C30H44N8O5 (596.3434)


   

Arg Phe Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]hexanamido]-3-phenylpropanoic acid

C30H44N8O5 (596.3434)


   

Arg Lys Phe Phe

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]-3-phenylpropanamido]-3-phenylpropanoic acid

C30H44N8O5 (596.3434)


   

2-[5-[3-(5-Carboxypentyl)-1,3-dihydro-1,1-dimethyl-2H-benz[e]indol-2-ylidene]-1,3-pentadienyl]-3-ethyl-1,1-dimethyl-1H-benz[e]indolium inner salt

2-[5-[3-(5-Carboxypentyl)-1,3-dihydro-1,1-dimethyl-2H-benz[e]indol-2-ylidene]-1,3-pentadienyl]-3-ethyl-1,1-dimethyl-1H-benz[e]indolium inner salt

C41H44N2O2 (596.3403)


   

Deferoxamine hydrochloride

Deferoxamine hydrochloride

C25H49ClN6O8 (596.33)


D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

(2E,4E,9R)-9-hydroxy-10-[(2R,4R,6S)-6-[(S)-[[(2S)-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetyl]amino]-methoxymethyl]-4-methoxy-3,3-dimethyloxan-2-yl]deca-2,4-dienoate

(2E,4E,9R)-9-hydroxy-10-[(2R,4R,6S)-6-[(S)-[[(2S)-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetyl]amino]-methoxymethyl]-4-methoxy-3,3-dimethyloxan-2-yl]deca-2,4-dienoate

C31H50NO10- (596.3435)


   

S-hexadecanoyl-4-phosphopantetheine

S-hexadecanoyl-4-phosphopantetheine

C27H53N2O8PS (596.326)


An S-acyl-4-phosphopantetheine obtained by formal condensation of the thiol group of D-pantetheine 4-phosphate with the carboxy group of hexadecanoic acid.

   

PG O-22:2;O2

PG O-22:2;O2

C28H53O11P (596.3325)


   

PG P-18:0/4:1;O2

PG P-18:0/4:1;O2

C28H53O11P (596.3325)


   

PG 14:0/8:1;O

PG 14:0/8:1;O

C28H53O11P (596.3325)


   

PG 18:0/4:1;O

PG 18:0/4:1;O

C28H53O11P (596.3325)


   

PG 22:1;O

PG 22:1;O

C28H53O11P (596.3325)


   

ST 29:6;O2;GlcA

ST 29:6;O2;GlcA

C35H48O8 (596.3349)


   

ST 29:7;O3;Hex

ST 29:7;O3;Hex

C35H48O8 (596.3349)


   

(2s)-n-(5-carbamimidamido-1-oxopentan-2-yl)-2-[(2-{[1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxy-4-phenylbutylidene)amino]-4-methylpentanimidic acid

(2s)-n-(5-carbamimidamido-1-oxopentan-2-yl)-2-[(2-{[1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxy-4-phenylbutylidene)amino]-4-methylpentanimidic acid

C31H44N6O6 (596.3322)


   

(2r,3r)-n-(5-carbamimidamido-1-oxopentan-2-yl)-2-[(2-{[1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxy-4-phenylbutylidene)amino]-3-methylpentanimidic acid

(2r,3r)-n-(5-carbamimidamido-1-oxopentan-2-yl)-2-[(2-{[1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxy-4-phenylbutylidene)amino]-3-methylpentanimidic acid

C31H44N6O6 (596.3322)


   

5-hydroxy-2-(2-{2-[2-(2-hydroxy-3-methylpentanoyl)-1,2-diazinane-3-carbonyl]-1,2-diazinane-3-carbonyl}-1,2-diazinane-3-carbonyl)-1,2-diazinane-3-carboxylic acid

5-hydroxy-2-(2-{2-[2-(2-hydroxy-3-methylpentanoyl)-1,2-diazinane-3-carbonyl]-1,2-diazinane-3-carbonyl}-1,2-diazinane-3-carbonyl)-1,2-diazinane-3-carboxylic acid

C26H44N8O8 (596.3282)


   

[(1r,5ar,7r,8r,9as,10r,11r,11ar)-11-(acetyloxy)-8,10-dihydroxy-6,6,9a,11a-tetramethyl-1-(6-methyl-5-methylideneheptan-2-yl)-1h,2h,3h,3ah,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl]oxidanesulfonic acid

[(1r,5ar,7r,8r,9as,10r,11r,11ar)-11-(acetyloxy)-8,10-dihydroxy-6,6,9a,11a-tetramethyl-1-(6-methyl-5-methylideneheptan-2-yl)-1h,2h,3h,3ah,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl]oxidanesulfonic acid

C32H52O8S (596.3383)